{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:43:26Z","timestamp":1754160206669,"version":"3.41.2"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clineuro.2025.109032","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:42:03Z","timestamp":1750851723000},"page":"109032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comment on: \"Vestibular migraine: Onabotulinum toxin effectivity, prospective-randomized study\""],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2678-4076","authenticated-orcid":false,"given":"Aman","family":"Advani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.109032_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2025.108949","article-title":"Vestibular migraine: onabotulinum toxin effectivity, prospective-randomized study","volume":"254","author":"Surmeli","year":"2025","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1-2","key":"10.1016\/j.clineuro.2025.109032_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline","volume":"331","author":"Silberstein","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109032_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/lary.25445","article-title":"Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial","volume":"126","author":"Salviz","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clineuro.2025.109032_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.955158","article-title":"A preliminary trial of botulinum toxin type A in patients with vestibular migraine: a longitudinal fMRI study","volume":"13","author":"Oh","year":"2022","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109032_bib5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/01.wnl.0000237539.09942.06","article-title":"Migrainous vertigo: prevalence and impact on quality of life","volume":"67","author":"Neuhauser","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109032_bib6","first-page":"436","article-title":"\"Vestibular migraine\": effects of prophylactic therapy with various drugs","volume":"256","author":"Baier","year":"2009","journal-title":"A Retrosp. Study J. Neurol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725003154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725003154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T06:03:21Z","timestamp":1753509801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725003154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":6,"alternative-id":["S0303846725003154"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109032","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on: \"Vestibular migraine: Onabotulinum toxin effectivity, prospective-randomized study\"","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109032"}}